InvestorsHub Logo

Den

Followers 788
Posts 99329
Boards Moderated 7
Alias Born 07/05/2006

Den

Re: None

Thursday, 12/08/2016 5:18:22 AM

Thursday, December 08, 2016 5:18:22 AM

Post# of 9911
ENTB got news / biotech one - low floater


Zander Therapeutics Inc. is a wholly owned subsidiary of Entest BioMedical Inc. (PINKS: ENTB). David R. Koos serves as Chairman and Chief Executive Officer of Regen, Entest Biomedical, Inc. and Zander Therapeutics.

NEWS < http://www.otcmarkets.com/stock/ENTB/news

low floater

chart


Disclaimer: pinky rhymes with stinky > don't buy stocks before making some DD / trust ppl u have faith in, don't take my posts for recommandation to buy or sell - do ur OWN DD

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.